RETRACTION article

Front. Pharmacol., 06 September 2023

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1285746

Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway

The journal retracts the 02 July 2019 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors agree with this retraction.

Summary

Keywords

colorectal cancer (CRC), ubiquitous mitochondrial creatine kinase (uMtCK), proliferation, invasion, Carcinogenesis

Citation

Frontiers Editorial Office (2023) Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway. Front. Pharmacol. 14:1285746. doi: 10.3389/fphar.2023.1285746

Received

30 August 2023

Accepted

30 August 2023

Published

06 September 2023

Approved by

Angelo A. Izzo, University of Naples Federico II, Italy

Volume

14 - 2023

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics